Remember me

[ ]
Go to site
Consorzio per il Centro di Biomedicina Molecolare (CBM)

CBM aims to become a leading provider of preclinical services in Central Europe and beyond. Its expertise includes most-omics technologies for biomarker discovery (genomics, proteomics, metabonomics) complemented by a qualified bioinformatics team available for routine services as well as custom and integrated research projects. The preclinical characterization of novel therapeutics targets is ensured by an integrated facility for in vivo and in vitro optical imaging studies, and the validation within a clinical setting is ensured by our facility located at the Oncological Reference Centre of Aviano providing pharmacogenetics, pharmacoproteomics and pharmacokinetics studies. The Optical Imaging Laboratory, set up in cooperation with Bracco Imaging S.p.A., is equipped for optical imaging acquisition and analysis, fluorescent tracers synthesis, cell culture and animal housing. The Bioinformatics Laboratory acts as a catalyst for improving experimental design, data production and data analysis in highly integrative "-omics" projects. The combination of backgrounds in the team, spanning across various branches of biology as well as physics, mathematics and IT, and the presence of several "-omics" facilities at CBM allows it to tackle complex projects ensuring a robust IT approach on the one hand, complemented by a thorough understanding of the biology on the other hand. The laboratory integrates biostatistics and bioinformatics approaches, ensuring organization and analysis of complex datasets. The Genomics Laboratory pursue advanced genomics research. It is equipped with Illumina and Affymetrix machines to perform expression profiling and genotyping assays using microarrays.

Website: www.cbm.fvg.it

CBM Scrl, Strada Statale 14 - km 163,5 AREA Science Park, 34149 Basovizza, Trieste ITALY
Search P3AGI
Site Translator
Upcoming Events
There are no events scheduled in the next 150 days

The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7 (2007-2013)) under grant no. 230739